Fosamax

Pharmaceutical

Wesley Chadwick Cook has been selected to serve on Plaintiffs Steering Committee (PSC) for the consolidated litigation of cases involving the Fosamax Femur Fracture multidistrict litigation (MDL)



Pharmaceutical

The osteoporosis drug Fosamax has updated the Warnings, Adverse Reactions, and Patient Information sections of its safety label to revise information on Osteonecrosis of the Jaw (ONJ) and upper gastrointestinal adverse reactions, as well include post-marketing experiences on ONJ and thigh fractures, according to the Food and Drug Administration (FDA).




Pharmaceutical

Merck & Co on Tuesday is slated to fight the first of numerous U.S. lawsuits brought by patients who claim they suffered jaw damage from the company's widely used Fosamax treatment for osteoporosis.




Pharmaceutical

The Los Angeles Times on Sunday examined how the business "strategy that has made the pharmaceutical industry one of the wealthiest and most powerful on Earth" might have begun to "betray it."



Pharmaceutical

Readington-based Merck & Co.'s Fosamax, Novartis AG's Reclast and similar medicines for thin, weak bones may produce severe joint and muscle pain, U.S. regulators said.



Pharmaceutical

The Food and Drug Administration (FDA) is going to be taking another look at Fosamax and other bone building drugs because they could be causing irregular heartbeats in some patients.



Pharmaceutical

The Food and Drug Administration said Monday it's conducting a safety review of bone-building drugs to see if there's a link to atrial fibrillation, a heart rhythm disorder.



Pharmaceutical

The Food and Drug Administration said Monday it's conducting a safety review of bone-building drugs to see if there's a link to atrial fibrillation, a heart rhythm disorder.



Pharmaceutical

Seven (7) residents of Texas have filed lawsuit against Merck Pharmaceuticals claiming that the drug, Fosamax, which is used to treat osteoporosis, is defective.



Pharmaceutical

A Lubbock woman has filed a lawsuit, saying the maker of Fosamax failed to warn consumers about potentially deadly side affects.